Biotech
> Novogen ($NVGN) appointed Dr. James Garner as CEO. Release
> Therabron promoted Thomas Miller to president and CEO and appointed Aprile Pilon to executive vice president and chief scientific officer and Anita Fauchier as vice president of regulatory affairs and quality assurance. Release
> Huya Biosciences International named Dr. Dmitri Kharkevitch as vice president of clinical development oncology. Release
> Scilex Pharma hired Dean Ferrigno as vice president of finance and Kip Vought as vice president of development. Release
> Symic appointed Seema Kantak as chief scientific officer. Release
> The Medicines Company ($MDCO) President and Chief Financial Officer Glenn Sblendorio will retire effective March 31, 2016. Release
> Benitec ($BNTCW) CEO and Managing Director Dr. Peter French will step down. Current Chief Financial Officer and Company Secretary Greg West will step in as interim CEO. Release
> Tiziana Life Sciences named James Tripp as chief operating officer. Release
> Biothera Pharmaceutical appointed Barry Labinger as CEO. Release
> Cellnovo Group named Javaid Masoud as chief technology officer. Release
> Idea Pharma appointed Mark Forbes Irving as managing director. Release
> Lisa Miller joined Metabolon as vice president of precision medicine. Release
> CoLucid Pharma ($CLCD) appointed Raymond Skwierczynski as head of its pharmaceutical operations. Release
> AgeneBio brought on Richard Mohs as its vice president of clinical development. Release
> Envisia Therapeutics named William Yelle its executive chairman. Release
> RDD Pharma named Dr. June Almenoff its board chairman. Release
> Dr. Dennis Langer joined enGene's board of directors. Release
> Pulmatrix ($PULM) appointed Mark Iwicki as its chairman of the board. Release
> BrainStorm named Revital Geffen-Aricha as its vice president of R&D. Release
> G. John Mohr joined Immune Pharma as its senior vice president of business development. Release
> Regulus ($RGLS) brought on Joseph Hagan as its chief operating officer. Release
> Ignyta ($RXDX) appointed William McCarthy as its chief business officer. Release
> Syros Pharmaceuticals named Dr. David Roth as its chief medical officer. Release
> Caligor Rx appointed Michael Dallmann as its director of strategic planning. Release
Med tech
> GlucoTrack hired Boudewijn Baks as international sales and business development manager for its GlucoTrack device. Release
|